Hepatic encephalopathy: features of pharmacotherapy

Abstract

The article presents contemporary views on the hepatic encephalopathy pathogenesis, as well as a brief overview of the therapy methods. It provides a review of the evidence-base for the efficacy of L-ornithine L-aspartate preparations. Clinical findings support the positive effect of intravenous administration of Ornilatex in patients with clinically significant manifestations of hepatic encephalopathy.

Keywords

• hepatic encephalopathy
• liver cirrhosis
• l-ornithine l-aspartate